ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+2.18%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$339M
AUM Growth
+$339M
(+12%)
Cap. Flow
+$29.1M
Cap. Flow
% of AUM
8.58%
Top 10 Holdings %
Top 10 Hldgs %
40.44%
Holding
118
New
22
Increased
42
Reduced
29
Closed
25
Top Buys
| 1 |
Merck
MRK
|
$9.08M |
| 2 |
Labcorp
LH
|
$7.04M |
| 3 |
Universal Health Services
UHS
|
$6.49M |
| 4 |
Johnson & Johnson
JNJ
|
$6.32M |
| 5 |
Becton Dickinson
BDX
|
$5.84M |
Top Sells
| 1 |
AMSG
Amsurg Corp
AMSG
|
$6.25M |
| 2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$5.94M |
| 3 |
Hologic
HOLX
|
$5.76M |
| 4 |
Teleflex
TFX
|
$4.42M |
| 5 |
Community Health Systems
CYH
|
$4.33M |
Sector Composition
| 1 | Healthcare | 89.84% |
| 2 | Financials | 0.85% |
| 3 | Technology | 0.78% |
| 4 | Real Estate | 0.25% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALR
26
DELISTED
AlerisLife Inc. Common Stock
ALR
| $4.29M | 1.27% |
89,335
+81,225
| +1,002% | +$3.9M |
|
27
Intuitive Surgical
ISRG
$158B
| $4.22M | 1.24% |
78,300
+9,900
| +14% | +$533K |
|
|
ESRX
28
DELISTED
Express Scripts Holding Company
ESRX
| $4.15M | 1.23% |
46,700
-22,500
| -33% | -$2M |
|
29
Novartis
NVS
$248B
| $4.15M | 1.22% |
47,095
-21,651
| -31% | -$1.91M |
|
30
Vertex Pharmaceuticals
VRTX
$102B
| $4.06M | 1.2% |
32,900
+18,500
| +128% | +$2.28M |
|
31
Baxter International
BAX
$12.1B
| $3.64M | 1.08% |
95,916
-10,862
| -10% | -$413K |
|
|
ELOS
32
DELISTED
Syneron Medical Ltd
ELOS
| $3.5M | 1.03% |
329,914
+231,114
| +234% | +$2.45M |
|
|
QGENF
33
DELISTED
QIAGEN NV
QGENF
| $3.21M | 0.95% |
+129,300
| New | +$3.21M |
|
|
KTWO
34
DELISTED
K2M Group Holdings, Inc
KTWO
| $2.91M | 0.86% |
121,133
-41,989
| -26% | -$1.01M |
|
|
AET
35
DELISTED
Aetna Inc
AET
| $2.87M | 0.85% |
22,550
-3,400
| -13% | -$433K |
|
36
Zimmer Biomet
ZBH
$20.8B
| $2.72M | 0.8% |
+25,647
| New | +$2.72M |
|
|
NSTG
37
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.71M | 0.8% |
175,961
-187,717
| -52% | -$2.89M |
|
38
Zevra Therapeutics
ZVRA
$501M
| $2.68M | 0.79% |
+9,106
| New | +$2.68M |
|
|
KND
39
DELISTED
Kindred Healthcare
KND
| $2.67M | 0.79% |
131,500
+59,100
| +82% | +$1.2M |
|
|
CSLT
40
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.66M | 0.78% |
326,223
+66,923
| +26% | +$545K |
|
41
Boston Scientific
BSX
$159B
| $2.57M | 0.76% |
145,100
-98,100
| -40% | -$1.74M |
|
42
Agilent Technologies
A
$35.5B
| $2.46M | 0.72% |
63,665
-5,100
| -7% | -$197K |
|
|
CELG
43
DELISTED
Celgene Corp
CELG
| $2.37M | 0.7% |
20,460
-9,500
| -32% | -$1.1M |
|
44
Amphastar Pharmaceuticals
AMPH
$1.37B
| $2.35M | 0.69% |
133,559
-18,600
| -12% | -$327K |
|
|
BDSI
45
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.33M | 0.69% |
293,100
+270,400
| +1,191% | +$2.15M |
|
46
Viatris
VTRS
$12.3B
| $2.18M | 0.64% |
32,100
+22,500
| +234% | +$1.53M |
|
47
Humana
HUM
$37.5B
| $2.12M | 0.63% |
11,098
-1,300
| -10% | -$249K |
|
|
PARN
48
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
| $2.02M | 0.59% |
407,143
+119,980
| +42% | +$594K |
|
49
Cigna
CI
$80.2B
| $1.98M | 0.58% |
12,200
-1,400
| -10% | -$227K |
|
50
Jazz Pharmaceuticals
JAZZ
$7.99B
| $1.94M | 0.57% |
11,000
+300
| +3% | +$52.8K |
|